Author:
Kataria Kamal,Pattashanee Santosha,Gupta Komal,Ranjan Piyush,Dhar Anita,Srivastava Anurag,Tandon Radhika
Publisher
Springer Science and Business Media LLC
Reference8 articles.
1. Kahaly GJ, Diana T, Glang J, Kanitz M, Pitz S, König J (2016) Thyroid stimulating antibodies are highly prevalent in hashimoto’s thyroiditis and associated orbitopathy. J Clin Endocrinol Metab 101(5):1998–2004
2. Tanda ML, Piantanida E, Liparulo L, Veronesi G, Lai A, Sassi L, Pariani N, Gallo D, Azzolini C, Ferrario M, Bartalena L (2013) Prevalence and natural history of graves’ orbitopathy in a large series of patients with newly diagnosed graves’ hyperthyroidism seen at a single center. J Clin Endocrinol Metab 98(4):1443–1449
3. Bartley GB (1994) The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Opthalmol Soc 92:477–588
4. De Juan E Jr, Hurley DP, Sapira JD (1980) Racial differences in normal values of proptosis. Arch Intern Med 140(9):1230–1231
5. Suzuki N, Noh JY, Kameda T et al (2018) Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease. Clin Ophthalmol 19(12):739–746